Top

Endocrine

Published in:

26-12-2023 | Subacute Granulomatous Thyroiditis | Review

The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis

Authors: Arman Shekarian, Mohammad Fakhrolmobasheri, Sadegh Mazaheri-Tehrani, Amirhossein Yousefian, Maryam Heidarpour

Published in: Endocrine | Issue 1/2024

Abstract

Purpose:

Subacute thyroiditis (SAT) is a transient inflammatory disorder of the thyroid gland with a possible viral etiology. We conducted this study to estimate the pooled prevalence of thyroid autoantibodies in SAT patients. This question arose due to the varying reports on the positivity rates of thyroid autoantibodies among SAT patients.

Methods:

We searched PubMed, Embase, Scopus, and Web of Science from their inception until March 25th, 2023. Observational studies reporting the positivity rate of thyroid autoantibodies for more than ten patients were included. We used the Joanna Briggs Institute’s (JBI) critical appraisal checklist to assess the quality of the included studies. Pooled prevalence estimates with 95% confidence intervals were calculated using the random effects model. Subgroup analyses were performed to find sources of heterogeneity.

Results:

Out of 1373 identified records, 32 studies involving 2348 SAT patients were included in our study. Thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) were positive in 22.8% and 12.2% of patients, respectively. The Study design, mean erythrocyte sedimentation rate and mean thyroid-stimulating hormone of patients were identified as sources of heterogeneity. As our secondary objectives, we found a recurrence rate of 14.7% and permanent hypothyroidism in 11.6% of patients.

Conclusion:

The results of our study revealed a low TPOAb positivity rate in SAT patients, consistent with its non-autoimmune etiology. The TgAb positivity rate in SAT patients was higher than that of the general population, possibly explained by the transient release of thyroglobulin into the bloodstream during the thyrotoxic phase, leading to subsequent TgAb production. Furthermore, our findings demonstrate a notable recurrence rate and permanent hypothyroidism among SAT patients, highlighting the importance of ongoing follow-up care.

Available only for authorised users

M. Popescu, A. Ghemigian, C.M. Vasile, A. Costache, M. Carsote, A.E. Ghenea, The new entity of subacute thyroiditis amid the COVID-19 pandemic: from infection to vaccine. Diagnostics (Basel) 12, 960 (2022). https://doi.org/10.3390/diagnostics12040960CrossRefPubMed

N. Erdem, M. Erdogan, M. Ozbek, M. Karadeniz, S. Cetinkalp, A.G. Ozgen, F. Saygili, C. Yilmaz, M. Tuzun, T. Kabalak, Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey. J. Endocrinol. Invest. 30, 546–550 (2007). https://doi.org/10.1007/BF03346347CrossRefPubMed

V. Fatourechi, J.P. Aniszewski, G.Z.E. Fatourechi, E.J. Atkinson, S.J. Jacobsen, Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J. Clin. Endocrinol. Metab. 88, 2100–2105 (2003). https://doi.org/10.1210/jc.2002-021799CrossRefPubMed

P. He, H. Yang, Q. Lai, Y. Kuang, Z. Huang, X. Liang, H. Huang, Y. Qin, Z. Luo, The diagnostic value of blood cell-derived indexes in subacute thyroiditis patients with thyrotoxicosis: a retrospective study. Ann. Transl. Med. 10, 322 (2022). https://doi.org/10.21037/atm-22-719CrossRefPubMedPubMedCentral

J. Görges, J. Ulrich, C. Keck, D. Müller-Wieland, S. Diederich, O.E. Janssen, Long-term outcome of subacute thyroiditis. Exp. Clin. Endocrinol Diabetes 128, 703–708 (2020). https://doi.org/10.1055/a-0998-8035CrossRefPubMed

J. Zhang, G. Ding, J. Li, X. Li, L. Ding, X. Li, S. Yang, F. Tang, Risk factors for subacute thyroiditis recurrence: A systematic review and meta-analysis of cohort studies. Front Endocrinol (Lausanne) 12, 783439 (2021). https://doi.org/10.3389/fendo.2021.783439CrossRefPubMed

S.N. Dwivedi, T. Kalaria, H. Buch, Thyroid autoantibodies. J. Clin. Pathol 76, 19–28 (2023). https://doi.org/10.1136/jcp-2022-208290CrossRefPubMed

J. Klubo-Gwiezdzinska, L. Wartofsky, Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol. Arch. Intern. Med. 132, 16222 (2022). https://doi.org/10.20452/pamw.16222CrossRefPubMedPubMedCentral

F. Bogazzi, L. Bartalena, S. Brogioni, A. Burelli, L. Manetti, M.L. Tanda, M. Gasperi, E. Martino, Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur. J. Endocrinol 140, 452–456 (1999). https://doi.org/10.1530/eje.0.1400452CrossRefPubMed

10.

M.E. Sencar, M. Calapkulu, D. Sakiz, S. Hepsen, A. Kus, P. Akhanli, I.O. Unsal, M. Kizilgul, B. Ucan, M. Ozbek, E. Cakal, An evaluation of the results of the steroid and non-steroidal anti-inflammatory drug treatments in subacute thyroiditis in relation to persistent hypothyroidism and recurrence. Sci. Rep. 9, 16899 (2019). https://doi.org/10.1038/s41598-019-53475-wCrossRefPubMedPubMedCentral

11.

N. Omori, K. Omori, K. Takano, Association of the ultrasonographic findings of subacute thyroiditis with thyroid pain and laboratory findings. Endocr. J. 55, 583–588 (2008). https://doi.org/10.1507/endocrj.k07e-163CrossRefPubMed

12.

J. Sato, T. Uchida, K. Komiya, H. Goto, K. Takeno, R. Suzuki, A. Honda, M. Himuro, H. Watada, Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 55, 209–214 (2017). https://doi.org/10.1007/s12020-016-1122-3CrossRefPubMed

13.

E. Nishihara, N. Amino, T. Kudo, K. Kohsaka, M. Ito, S. Fukata, M. Nishikawa, H. Nakamura, A. Miyauchi, Moderate frequency of anti-thyroglobulin antibodies in the early phase of subacute thyroiditis. Eur. Thyroid. J. 8, 268–272 (2019). https://doi.org/10.1159/000501033CrossRefPubMedPubMedCentral

14.

Ç.T. Bahadir, M. Yilmaz, E. Kiliçkan, Factors affecting recurrence in subacute granulomatous thyroiditis. Arch. Endocrinol. Metab. 66, 286–294 (2022). https://doi.org/10.20945/2359-3997000000473CrossRefPubMedPubMedCentral

15.

D. Fadime, Cut off value of technetium uptake in the differential diagnosis of Graves, disease and subacute thyroiditis. Asia Ocean J. Nucl. Med. Biol. 8, 54–57 (2020). https://doi.org/10.22038/aojnmb.2019.14241CrossRefPubMedPubMedCentral

16.

M.A. Hasanat, M.A. Rumi, M.N. Alam, K.N. Hasan, M. Salimullah, M.A. Salam, M. Fariduddin, H. Mahtab, A.K. Khan, Status of antithyroid antibodies in Bangladesh. Postgrad. Med. J. 76, 345–349 (2000). https://doi.org/10.1136/pmj.76.896.345CrossRefPubMedPubMedCentral

17.

M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hróbjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuinness, L.A. Stewart, J. Thomas, A.C. Tricco, V.A. Welch, P. Whiting, D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021). https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

18.

Z. Munn, S. Moola, K. Lisy, D. Riitano, C. Tufanaru, Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int. J. Evid. Based Healthc 13, 147–153 (2015). https://doi.org/10.1097/XEB.0000000000000054CrossRefPubMed

19.

C.B. Begg, M. Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101 (1994)CrossRefPubMed

20.

M. Egger, G. Davey Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997). https://doi.org/10.1136/bmj.315.7109.629CrossRefPubMedPubMedCentral

21.

S. Duval, R. Tweedie, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455–463 (2000). https://doi.org/10.1111/j.0006-341x.2000.00455.xCrossRefPubMed

22.

J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol Metab. 87, 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182CrossRefPubMed

23.

A. Amouzegar, S. Gharibzadeh, E. Kazemian, L. Mehran, M. Tohidi, F. Azizi, The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran Thyroid Study. PLoS One 12, e0169283 (2017). https://doi.org/10.1371/journal.pone.0169283CrossRefPubMedPubMedCentral

24.

M.P. Baruah, B. Bhattacharya, U.M. Baruah, C-Reactive Protein Level can be a Better Indicator than Erythrocyte Sedimentation Rate in Assessing the Severity of Inflammation and Guiding Glucocorticoid Therapy in Subacute Thyroiditis. Indian J. Endocrinol Metab. 26, 328–333 (2022). https://doi.org/10.4103/ijem.ijem_229_22CrossRefPubMedPubMedCentral

25.

A. Brancatella, N. Viola, G. Rutigliano, D. Sgrò, F. Santini, F. Latrofa, Subacute Thyroiditis during the SARS-CoV-2 pandemic. J. Endocr. Soc. 5, bvab130 (2021). https://doi.org/10.1210/jendso/bvab130CrossRefPubMedPubMedCentral

26.

K. Luotola, P. Mantula, J. Salmi, A.M. Haapala, P. Laippala, M. Hurme, Allele 2 of interleukin-1 receptor antagonist gene increases the risk of thyroid peroxidase antibodies in subacute thyroiditis. APMIS 109, 454–460 (2001). https://doi.org/10.1034/j.1600-0463.2001.090608.xCrossRefPubMed

27.

C.A. Spencer, M. Takeuchi, M. Kazarosyan, C.C. Wang, R.B. Guttler, P.A. Singer, S. Fatemi, J.S. LoPresti, J.T. Nicoloff, Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 83, 1121–1127 (1998). https://doi.org/10.1210/jcem.83.4.4683CrossRefPubMed

28.

Y. Li, D. Teng, Z. Shan, X. Teng, H. Guan, X. Yu, C. Fan, W. Chong, F. Yang, H. Dai, X. Gu, Y. Yu, J. Mao, D. Zhao, J. Li, Y. Chen, R. Yang, C. Li, W. Teng, Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J. Clin. Endocrinol. Metab. 93, 1751–1757 (2008). https://doi.org/10.1210/jc.2007-2368CrossRefPubMed

29.

D. Ricci, A. Brancatella, M. Marinò, M. Rotondi, L. Chiovato, P. Vitti, F. Latrofa, The detection of serum IgMs to thyroglobulin in subacute thyroiditis suggests a protective role of IgMs in thyroid autoimmunity. J. Clin. Endocrinol Metab. 105, dgaa038 (2020). https://doi.org/10.1210/clinem/dgaa038CrossRefPubMed

30.

R. Volpé, V.V. Row, C. Ezrin, Circulating viral and thyroid antibodies in subacute thyroiditis. J. Clin. Endocrinol Metab. 27, 1275–1284 (1967). https://doi.org/10.1210/jcem-27-9-1275CrossRefPubMed

31.

A. Kotwal, M. Stan, Thyrotropin receptor antibodies-an overview. Ophthalmic Plast Reconstr. Surg. 34, S20–S27 (2018). https://doi.org/10.1097/IOP.0000000000001052CrossRefPubMed

32.

G. Barbesino, Y. Tomer, Clinical review: Clinical utility of TSH receptor antibodies. J. Clin. Endocrinol Metab. 98, 2247–2255 (2013). https://doi.org/10.1210/jc.2012-4309CrossRefPubMedPubMedCentral

33.

T. Diana, K.A. Ponto, G.J. Kahaly, Thyrotropin receptor antibodies and Graves’ orbitopathy. J. Endocrinol Invest. 44, 703–712 (2021). https://doi.org/10.1007/s40618-020-01380-9CrossRefPubMed

34.

M. Stasiak, B. Tymoniuk, B. Stasiak, A. Lewiński, The risk of recurrence of subacute thyroiditis is HLA-dependent. Int. J. Mol. Sci. 20, 1089 (2019). https://doi.org/10.3390/ijms20051089CrossRefPubMedPubMedCentral

35.

D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, M.A. Walter, 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421 (2016). https://doi.org/10.1089/thy.2016.0229CrossRefPubMed

36.

A. Saklamaz, Is there a drug effect on the development of permanent hypothyroidism in subacute thyroiditis? Acta Endocrinol (Buchar) 13, 119–123 (2017). https://doi.org/10.4183/aeb.2017.119CrossRefPubMed

37.

M. Ziaka, A. Exadaktylos, Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine. Virol J. 20, 132 (2023). https://doi.org/10.1186/s12985-023-02103-1CrossRefPubMedPubMedCentral

38.

M. Rotondi, F. Coperchini, G. Ricci, M. Denegri, L. Croce, S.T. Ngnitejeu, L. Villani, F. Magri, F. Latrofa, L. Chiovato, Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol Invest 44, 1085–1090 (2021). https://doi.org/10.1007/s40618-020-01436-wCrossRefPubMed

39.

M. Stasiak, A. Lewiński, New aspects in the pathogenesis and management of subacute thyroiditis. Rev. Endocr. Metab. Disord. 22, 1027–1039 (2021). https://doi.org/10.1007/s11154-021-09648-yCrossRefPubMedPubMedCentral

40.

N. Viola, A. Brancatella, D. Sgrò, F. Santini, F. Latrofa, Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review. Endocrine 79, 448–454 (2023). https://doi.org/10.1007/s12020-022-03247-wCrossRefPubMed

41.

E. Meftah, R. Rahmati, F. Zari Meidani, S. Khodadadi, K. Chitzan-Zadeh, F. Esfahanian, S. Afshar, Subacute thyroiditis following COVID-19: A systematic review. Front Endocrinol (Lausanne) 14, 1126637 (2023). https://doi.org/10.3389/fendo.2023.1126637CrossRefPubMed

42.

N. Araki, M. Iida, N. Amino, S. Morita, A. Ide, E. Nishihara, M. Ito, J. Saito, T. Nishikawa, K. Katsuragi, A. Miyauchi, Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. Eur. Thyroid J. 4, 14–19 (2015). https://doi.org/10.1159/000371740CrossRefPubMedPubMedCentral

43.

P.G. Espinoza, C.L. Guendelman, L.N. Quevedo Limón, R.J. Fernández, A comparison between two imaging techniques for the diagnosis of subacute thyroiditis (de Quervain thyroiditis): brief communication. Clin. Nucl. Med. 35, 862–864 (2010). https://doi.org/10.1097/RLU.0b013e3181f49adcCrossRefPubMed

44.

S. Hepsen, P. Akhanli, M.E. Sencar, H. Duger, D. Sakiz, M. Kizilgul, I. Ozturk Unsal, B. Ucan, M. Ozbek, E. Cakal, The evaluation of low- and high-dose steroid treatments in subacute thyroiditis: A retrospective observational study. Endocr Pract 27, 594–600 (2021). https://doi.org/10.1016/j.eprac.2020.11.009CrossRefPubMed

45.

K. Kamijo, K. Ishikawa, M. Tanaka, Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr. J. 52, 525–529 (2005). https://doi.org/10.1507/endocrj.52.525CrossRefPubMed

46.

K. Kamijo, H. Murayama, T. Uzu, K. Togashi, G.J. Kahaly, A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves’ disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells. Thyroid 20, 851–856 (2010). https://doi.org/10.1089/thy.2010.0059CrossRefPubMed

47.

S.H. Khan, A. Mahajan, B.A. Laway, R. Rasool, T.A. Rather, Technetium-99m Thyroid Scintigraphy and Human Leukocyte Antigen – B35 in Sub-Acute Thyroiditis. Indian J. Nucl. Med. 33, 306–311 (2018). https://doi.org/10.4103/ijnm.IJNM_74_18CrossRefPubMedPubMedCentral

48.

J. Kim, H.-S. Baek, J. Ha, M.K. Kim, H.-S. Kwon, K.-H. Song, D.-J. Lim, K.-H. Baek, Differential diagnosis of thyrotoxicosis by machine learning models with laboratory findings. Diagnostics (Basel) 12, 1468 (2022). https://doi.org/10.3390/diagnostics12061468CrossRefPubMed

49.

J.I. Lee, H.W. Jang, S.K. Kim, J.Y. Choi, J.Y. Kim, K.Y. Hur, J.H. Kim, Y.-K. Min, J.H. Chung, S.W. Kim, Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves’ disease. Korean J. Intern Med. 26, 179–186 (2011). https://doi.org/10.3904/kjim.2011.26.2.179CrossRefPubMedPubMedCentral

50.

J. Yoshimura Noh, N. Miyazaki, K. Ito, K. Takeda, S. Hiramatsu, S. Morita, A. Miyauchi, T. Murakami, K. Inomata, S. Noguchi, T. Satoh, N. Amino, Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid 18, 1157–1164 (2008). https://doi.org/10.1089/thy.2008.0119CrossRefPubMed

51.

H. Ota, N. Amino, S. Morita, K. Kobayashi, S. Kubota, S. Fukata, N. Kamiyama, A. Miyauchi, Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves’ disease. Clin. Endocrinol (Oxf) 67, 41–45 (2007). https://doi.org/10.1111/j.1365-2265.2007.02832.xCrossRefPubMed

52.

M. Schott, D. Hermsen, M. Broecker-Preuss, M. Casati, J.C. Mas, A. Eckstein, D. Gassner, R. Golla, C. Graeber, J. van Helden, K. Inomata, J. Jarausch, J. Kratzsch, N. Miyazaki, M.A.N. Moreno, T. Murakami, H.J. Roth, W. Stock, J.Y. Noh, W.A. Scherbaum, K. Mann, Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trial. Clin. Endocrinol (Oxf) 71, 566–573 (2009). https://doi.org/10.1111/j.1365-2265.2008.03512.xCrossRefPubMed

53.

M.E. Sencar, M. Çalapkulu, D. Sakiz, S. Hepsen, P. Akhanli, İ. Öztürk Ünsal, E. Çakal, Frequency of thyroid antibodies at the diagnosis of subacute thyroiditis. Turk. J. Endocrinol Metab. 24, 144–148 (2020). https://doi.org/10.25179/tjem.2020-74287CrossRef

54.

M. Stasiak, R. Michalak, B. Stasiak, A. Lewinski, Clinical characteristics of subacute thyroiditis is different than it used to be - current state based on 15 years own material. Neuro Endocrinol Lett. 39, 489–495 (2019)PubMed

55.

N. Takasu, K. Kamijo, Y. Sato, H. Yoshimura, A. Nagata, Y. Ochi, Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves’ disease. Clin. Exp. Pharmacol Physiol. 31, 314–319 (2004). https://doi.org/10.1111/j.1440-1681.2004.03991.xCrossRefPubMed

56.

J.R. Wall, C.R. Strakosch, P. Bandy, R. Bayly, Nature of thyrotropin displacement activity in subacute thyroiditis. J. Clin. Endocrinol Metab. 54, 349–353 (1982). https://doi.org/10.1210/jcem-54-2-349CrossRefPubMed

57.

Y. Thewjitcharoen, K. Sirinate, B. Siriwan, N. Soontaree, H. Thep, Clinical features and outcomes of subacute thyroiditis in Thai patients. JAFES 30, 125–128 (2015). https://doi.org/10.15605/jafes.030.02.03CrossRef

58.

Y. Zhou, M. Zhou, Y. Qi, W. Wang, X. Chen, S. Wang, The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease. Ther. Adv. Endocrinol Metab. 12, 20420188211044943 (2021). https://doi.org/10.1177/20420188211044943CrossRefPubMedPubMedCentral

Title: The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis
Authors: Arman Shekarian
Mohammad Fakhrolmobasheri
Sadegh Mazaheri-Tehrani
Amirhossein Yousefian
Maryam Heidarpour
Publication date: 26-12-2023
Publisher: Springer US
Keywords: Subacute Granulomatous Thyroiditis
Hypothyroidism
Published in: Endocrine / Issue 1/2024
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-023-03655-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose:

Methods:

Results:

Conclusion:

Please log in to get access to this content

Other articles of this Issue 1/2024

Werner syndrome in a patient with hyperglycemia

Polymorphisms in the Runx2 and osteocalcin genes affect BMD in postmenopausal women: a systematic review and meta-analysis

Re-assessment of the close relationship between serum FSH levels and semen quality: a retrospective cohort study of 11,929 Chinese men

Correlation between alternative insulin resistance indexes and diabetic kidney disease: a retrospective study

Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database

The impact of body mass index on operative time in transoral endoscopic thyroidectomy vestibular approach for thyroid cancer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials